Monday, December 20, 2021 4:30:19 PM
Mon, December 20, 2021, 11:02 AM
In this article:
GBT
+2.32%
Explore the topics mentioned in this article
Global Blood Therapeutics, Inc. GBT announced that the FDA has granted accelerated approval to its supplemental new drug application (“sNDA”) for Oxbryta (voxelotor) to treat sickle cell disease (“SCD”) in children aged four to less than 12 years.
The regulatory body also approved the new drug application (“NDA”) for Oxbryta tablets for oral suspension – a new dispersible, once-daily tablet dosage for patients aged four to less than 12 years, as well as for older patients who have difficulty swallowing whole tablets.
Oxbryta is currently approved by the FDA as an oral, once-daily treatment for SCD in patients aged 12 years or above.
The FDA nod for the sNDA was based on data from the phase IIa HOPE-KIDS 1 study, which evaluated Oxbryta in the given patient population. Data from the same showed that weight-based treatment with the dispersible tablet formulation of Oxbryta led to rapid and sustained improvements in hemoglobin. Concurrent reduction of hemolysis or red blood cell destruction was also demonstrated in the study.
Shares of Global Blood have plunged 29.5% so far this year compared with industry’s decrease of 19%.
Recent GBT News
- GROUPE BMTC INC. ANNONCE L'ACQUISITION D'UN CENTRE DE DISTRIBUTION À TERREBONNE AFIN DE GÉNÉRER DES REVENUS LOCATIFS À LONG TERME • PR Newswire (Canada) • 04/15/2024 11:30:00 PM
- BMTC GROUP INC. ANNOUNCES THE ACQUISITION OF A DISTRIBUTION CENTER TO GENERATE LONG-TERM RENTAL INCOME • PR Newswire (Canada) • 04/15/2024 11:30:00 PM
- GROUPE BMTC INC. ANNONCE LE RENOUVELLEMENT DE SON OFFRE DE RACHAT DANS LE COURS NORMAL DES ACTIVITÉS VISANT SES ACTIONS ORDINAIRES • PR Newswire (Canada) • 04/10/2024 11:30:00 PM
- BMTC GROUP INC. ANNOUNCES THE RENEWAL OF ITS NORMAL COURSE ISSUER BID TO ACQUIRE COMMON SHARES • PR Newswire (Canada) • 04/10/2024 11:30:00 PM
- GROUPE BMTC INC. ANNONCE SES RÉSULTATS FINANCIERS POUR LA PÉRIODE DE NEUF MOIS TERMINÉE LE 31 OCTOBRE 2023 • PR Newswire (Canada) • 12/12/2023 12:30:00 AM
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE NINE MONTH PERIOD ENDED OCTOBER 31st, 2023 • PR Newswire (Canada) • 12/12/2023 12:30:00 AM
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE SEMESTER ENDED JULY 31st, 2023 • PR Newswire (Canada) • 09/07/2023 11:30:00 PM
- GROUPE BMTC INC. ANNONCE SES RÉSULTATS FINANCIERS POUR LE SEMESTRE TERMINÉ LE 31 JUILLET 2023 • PR Newswire (Canada) • 09/07/2023 11:30:00 PM
- BMTC GROUP INC. ANNOUNCES THE ELECTION OF DIRECTORS • PR Newswire (Canada) • 06/08/2023 09:32:00 PM
- GROUPE BMTC INC. ANNONCE L'ÉLECTION DES ADMINISTRATEURS • PR Newswire (Canada) • 06/08/2023 09:30:00 PM
- BMTC GROUP INC. ANNOUNCES FINANCIAL RESULTS FOR THE QUARTER ENDED APRIL 30th, 2023 • PR Newswire (Canada) • 06/08/2023 06:00:00 PM
- GROUPE BMTC INC. ANNONCE SES RÉSULTATS FINANCIERS POUR LE TRIMESTRE TERMINÉ LE 30 AVRIL 2023 • PR Newswire (Canada) • 06/08/2023 06:00:00 PM
- Tanguay just moved in and is rolling out its experience across the province with 11 new stores • PR Newswire (Canada) • 05/16/2023 12:30:00 PM
- Tanguay arrive dans le décor et déploie son expérience à l'échelle de la province avec 11 nouveaux magasins • PR Newswire (Canada) • 05/16/2023 12:30:00 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM